Group 1 - The company, Rhein Biotech, stated on August 21 that its main products focus on functional ingredients and it currently has no plans for large-scale production of natural pigments [2]

Group 1 - The core viewpoint of the article indicates that the company, 莱茵生物 (Rhein Biotech), primarily focuses on functional ingredients and currently has no plans for large-scale production of natural pigments [1] Group 2 - The company engages in investor interactions to clarify its business direction and product focus [1] - The absence of plans for natural pigment production suggests a strategic emphasis on its existing product lines rather than diversifying into new areas at this time [1]

Group 1 - The core viewpoint is that if the FDA in the United States cancels synthetic dyes, there will be a significant increase in demand for natural dyes, but the company currently has no plans for large-scale production of natural dyes [2][3] - The company primarily focuses on functional ingredients and does not have immediate plans to adjust production to meet potential demand for natural dyes [2]